Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mm Hg Target? A Protagonist View From the SPRINT Trial (Systolic Blood Pressure Intervention Trial).
作者信息
Oparil Suzanne, Lewis Cora E
机构信息
From Department of Medicine, Division of Cardiovascular Disease, Vascular Biology and Hypertension Program, The University of Alabama at Birmingham (S.O.); and Department of Medicine, Division of Preventive Medicine, The University of Alabama at Birmingham (C.E.L.).
出版信息
Circulation. 2016 Nov 1;134(18):1308-1310. doi: 10.1161/CIRCULATIONAHA.116.023263. Epub 2016 Sep 12.
Abstract
摘要
相似文献
1
Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mm Hg Target? A Protagonist View From the SPRINT Trial (Systolic Blood Pressure Intervention Trial).
Circulation. 2016 Nov 1;134(18):1308-1310. doi: 10.1161/CIRCULATIONAHA.116.023263. Epub 2016 Sep 12.
2
Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mm Hg Target? An Antagonist View From the HOPE-3 Trial (Heart Outcomes Evaluation-3).
Circulation. 2016 Nov 1;134(18):1311-1313. doi: 10.1161/CIRCULATIONAHA.116.023264. Epub 2016 Sep 12.
3
In the Wake of Systolic Blood Pressure Intervention Trial: New Targets for Improving Hypertension Management in Chronic Kidney Disease?
Nephron. 2017;135(4):287-290. doi: 10.1159/000455130. Epub 2017 Feb 4.
4
Blood Pressure Variability Predicts Adverse Events and Cardiovascular Outcomes in Chronic Kidney Disease: A Post-Hoc Analysis of the SPRINT Trial.
Am J Hypertens. 2017 Dec 8;31(1):48-52. doi: 10.1093/ajh/hpx128.
5
Systolic Blood Pressure Intervention Trial (SPRINT) and Target Systolic Blood Pressure in Future Hypertension Guidelines.
Hypertension. 2016 Aug;68(2):318-23. doi: 10.1161/HYPERTENSIONAHA.116.07575. Epub 2016 Jun 27.
6
Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results.
J Am Heart Assoc. 2017 Nov 13;6(11):e007509. doi: 10.1161/JAHA.117.007509.
7
BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out?
Curr Cardiol Rep. 2016 Oct;18(10):98. doi: 10.1007/s11886-016-0775-0.
8
Multiphasic effects of blood pressure on survival in hemodialysis patients.
Kidney Int. 2016 Sep;90(3):674-84. doi: 10.1016/j.kint.2016.05.025.
9
Treatment of Hypertension: Which Goal for Which Patient?
Adv Exp Med Biol. 2017;956:117-127. doi: 10.1007/5584_2016_97.
10
Cardiovascular Risk in Hypertension in Relation to Achieved Blood Pressure Using Automated Office Blood Pressure Measurement.
Hypertension. 2016 Oct;68(4):866-72. doi: 10.1161/HYPERTENSIONAHA.116.07721. Epub 2016 Aug 15.
引用本文的文献
1
Blood pressure targets in adults with hypertension.
Cochrane Database Syst Rev. 2020 Dec 17;12(12):CD004349. doi: 10.1002/14651858.CD004349.pub3.
2
Risk Factors in Adolescence for the Development of Elevated Blood Pressure and Hypertension in American Indian and Alaskan Native Adults.
J Immigr Minor Health. 2021 Aug;23(4):717-724. doi: 10.1007/s10903-020-01130-2. Epub 2020 Nov 28.
3
Approaches for the Management of Resistant Hypertension in 2020.
Curr Hypertens Rep. 2020 Jan 8;22(1):3. doi: 10.1007/s11906-019-1013-0.
4
Determination of optimal on-treatment diastolic blood pressure range using automated measurements in subjects with cardiovascular disease-Analysis of a SPRINT trial subpopulation.
J Clin Hypertens (Greenwich). 2019 Jul;21(7):911-918. doi: 10.1111/jch.13581. Epub 2019 Jun 6.
5
Role of Coronary Artery Calcium for Stratifying Cardiovascular Risk in Adults With Hypertension.
Hypertension. 2019 May;73(5):983-989. doi: 10.1161/HYPERTENSIONAHA.118.12266.
6
Systolic Blood Pressure and Cognitive Decline in Older Adults With Hypertension.
Ann Fam Med. 2019 Mar;17(2):100-107. doi: 10.1370/afm.2367.
7
Burden of cardiovascular disease across 29 countries and GPs' decision to treat hypertension in oldest-old.
Scand J Prim Health Care. 2018 Mar;36(1):89-98. doi: 10.1080/02813432.2018.1426142. Epub 2018 Jan 25.
8
Hypertension highlights during 2016.
Ann Transl Med. 2017 Oct;5(20):404. doi: 10.21037/atm.2017.07.42.
9
Managing Hypertension in Patients Aged 75 Years and Older.
Curr Hypertens Rep. 2017 Oct 18;19(11):88. doi: 10.1007/s11906-017-0785-3.
10
Managing Hypertension in the Elderly: What is Different, What is the Same?
Curr Hypertens Rep. 2017 Aug;19(8):67. doi: 10.1007/s11906-017-0764-8.
本文引用的文献
1
Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.
JAMA. 2016 Jun 28;315(24):2673-82. doi: 10.1001/jama.2016.7050.
2
Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension.
Can J Cardiol. 2016 May;32(5):569-88. doi: 10.1016/j.cjca.2016.02.066. Epub 2016 Mar 10.
3
Generalizability of SPRINT Results to the U.S. Adult Population.
J Am Coll Cardiol. 2016 Feb 9;67(5):463-72. doi: 10.1016/j.jacc.2015.10.037. Epub 2015 Nov 9.
4
A Randomized Trial of Intensive versus Standard Blood-Pressure Control.
N Engl J Med. 2015 Nov 26;373(22):2103-16. doi: 10.1056/NEJMoa1511939. Epub 2015 Nov 9.
5
Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial.
Diabetes Care. 2014 Jun;37(6):1721-8. doi: 10.2337/dc13-2334. Epub 2014 Mar 4.
Zotero 插件